In particular, hypothalamic inhibition of IKKβ has shown striking metabolic benefit in preclinical models, restoring leptin and insulin sensitivity and preventing diet-induced obesity without causing systemic immune impairment [117]. Here, IKBKB is linked to obesity due to melanocortin 4 receptor deficiency.